Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;39(1):141-148.
doi: 10.1111/jgh.16362. Epub 2023 Sep 24.

Clinical outcomes and predictors for 30-day readmissions of endoscopic retrograde cholangiopancreatography in the United States

Affiliations

Clinical outcomes and predictors for 30-day readmissions of endoscopic retrograde cholangiopancreatography in the United States

Dushyant Singh Dahiya et al. J Gastroenterol Hepatol. 2024 Jan.

Abstract

Background/objectives: We aimed to assess 30-day readmissions of endoscopic retrograde cholangiopancreatography (ERCP) in the United States.

Methods: The National Readmission Database was utilized from 2016 to 2020 to identify 30-day readmissions of ERCP. Hospitalization characteristics and outcomes were compared between index hospitalizations and readmissions. Predictors of 30-day readmission and mortality were also identified.

Results: Between 2016 and 2020, 885 416 index hospitalizations underwent ERCP. Of these, 88 380 (10.15%) were readmitted within 30 days. Compared to index hospitalizations, 30-day readmissions had higher mean age (63.76 vs 60.8 years, P < 0.001) and proportion of patients with Charlson Comorbidity Index (CCI) score ≥3 (48.26% vs 29.91%, P < 0.001). Sepsis was the most common readmission diagnosis. Increasing age, male gender, higher CCI scores, admissions at large metropolitan teaching hospitals, cholecystectomy on index hospitalization, biliary stenting, increasing length of stay (LOS) at index admission, post-ERCP pancreatitis, post-ERCP hemorrhage, and gastrointestinal tract perforation were independent predictors of 30-day readmissions. Furthermore, 30-day readmissions had higher odds of inpatient mortality (4.42% vs 1.66%, aOR 1.9, 95% CI: 1.79-2.01, P < 0.001) compared to index hospitalizations. However, we noted a shorter LOS (5.78 vs 6.22 days, mean difference 1.2, 95% CI: 1.12-1.28, P < 0.001) and lower total hospital charge ($71 076 vs $93 418, mean difference $31 452, 95% CI: 29 835-33 069, P < 0.001) for 30-day readmissions compared to index hospitalizations. Increasing age, higher CCI scores, increasing LOS, biliary stenting, and post-ERCP hemorrhage were independent predictors of inpatient mortality for 30-day readmissions.

Conclusion: After index ERCP, the 30-day remission rate was 10.15%. Compared to index hospitalizations, 30-day readmissions had higher odds of inpatient mortality.

Keywords: Endoscopic retrograde cholangiopancreatography; Healthcare burden; Mortality; Outcomes; Readmission.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kröner PT, Bilal M, Samuel R et al. Use of ERCP in the United States over the past decade. Endosc. Int. Open. 2020; 8: E761-E769.
    1. Kozarek RA. The past, present, and future of endoscopic retrograde cholangiopancreatography. Gastroenterol. Hepatol. (N Y). 2017; 13: 620-622.
    1. Carr-Locke DL. Overview of the role of ERCP in the management of diseases of the biliary tract and the pancreas. Gastrointest. Endosc. 2002; 56: S157-S160.
    1. Dahiya DS, Perisetti A, Sharma N et al. Racial disparities in endoscopic retrograde cholangiopancreatography (ERCP) utilization in the United States: are we getting better? Surg. Endosc. 2023; 37: 421-433.
    1. Tarikci Kilic E, Kahraman R, Ozdil K. Evaluation of safety and outcomes of endoscopic retrograde cholangiopancreatography in 1337 patients at a single center. Medeni Med J. 2019; 34: 290-296 Epub 20190927.

LinkOut - more resources